Get started
Author

Paige M Mortimer

Observed names: Mortimer, Paige, Mortimer, Paige M, Mortimer, Paige Marie, Paige M. Mortimer, Paige Mortimer
ORCID: 0000-0002-8552-2996
Observed ORCID: 0000-0002-8552-2996
OpenAlex ID: A5054751979
Humoral and T-cell responses to SARS-CoV-2 vaccination in patients receiving immunosuppression
2021 · Maria Prendecki, Candice Clarke, et al. · Annals of the Rheumatic Diseases · 244
PDF
SARS-CoV-2-specific immune responses and clinical outcomes after COVID-19 vaccination in patients with immune-suppressive disease
2023 · Eleanor Barnes, Carl S. Goodyear, et al. · Nature Medicine · 139
PDF
Longitudinal proteomic profiling of dialysis patients with COVID-19 reveals markers of severity and predictors of death
2021 · Jack Gisby, Candice L Clarke, et al. · eLife · 71
Immunological responses to SARS-CoV-2 vaccines in kidney transplant recipients
2021 · Maria Prendecki, Tina Thomson, et al. · The Lancet · 70
PDF
Beyond the Extra Respiration of Phagocytosis: NADPH Oxidase 2 in Adaptive Immunity and Inflammation
2021 · Paige M. Mortimer, Stacey A. Mc Intyre, et al. · Frontiers in Immunology · 64
PDF
Multi-omics identify falling LRRC15 as a COVID-19 severity marker and persistent pro-thrombotic signals in convalescence
2022 · Jack S. Gisby, Norzawani B. Buang, et al. · Nature Communications · 39
PDF
Comparison of immunogenicity and clinical effectiveness between BNT162b2 and ChAdOx1 SARS-CoV-2 vaccines in people with end-stage kidney disease receiving haemodialysis: A prospective, observational cohort study
2022 · Paul Martin, Sarah Gleeson, et al. · The Lancet Regional Health - Europe · 35
PDF
Immunogenicity of third dose COVID-19 vaccine strategies in patients who are immunocompromised with suboptimal immunity following two doses (OCTAVE-DUO): an open-label, multicentre, randomised, controlled, phase 3 trial
2024 · Carl S Goodyear, Amit Patel, et al. · The Lancet Rheumatology · 30
EROS is a selective chaperone regulating the phagocyte NADPH oxidase and purinergic signalling
2022 · Lyra O. Randzavola, Paige M. Mortimer, et al. · eLife · 21
A novel mutation in EROS (CYBC1) causes chronic granulomatous disease
2023 · Paige M. Mortimer, Esme Nichols, et al. · Clinical Immunology · 20
PDF
Comparison of humoral and cellular responses in kidney transplant recipients receiving BNT162b2 and ChAdOx1 SARS-CoV-2 vaccines
2021 · Maria Prendecki, Tina Thomson, et al. · medRxiv · 18
PDF
Taurine transport is a critical modulator of ionic fluxes during NLRP3 inflammasome activation
2025 · Peter Rossi-Smith, Joohee Kim, et al. · Cell Reports · 13
Chronic granulomatous disease: lessons in cell biology from monogenic immunodeficiency
2025 · Paige M Mortimer, Shuli Svetitsky, et al. · Clinical & Experimental Immunology · 9
PDF
Longitudinal proteomic profiling of dialysis patients with COVID-19 reveals markers of severity and predictors of death
2020 · Jack Gisby, Candice L. Clarke, et al. · medRxiv · 8
PDF
Author response: Longitudinal proteomic profiling of dialysis patients with COVID-19 reveals markers of severity and predictors of death
2021 · Jack Gisby, Candice L Clarke, et al. · eLife · 4
CISH, a key intracellular checkpoint, in comparison and combination to existing and emerging cancer immune checkpoints
2026 · Florencia Cano, Alberto Bravo-Blas, et al. · Communications Biology · 2
PDF
Author response: EROS is a selective chaperone regulating the phagocyte NADPH oxidase and purinergic signalling
2022 · Lyra O Randzavola, Paige M Mortimer, et al. · eLife
Multi-omics identify LRRC15 as a COVID-19 severity predictor and persistent pro-thrombotic signals in convalescence
2022 · Gisby, Jack S, Norzawani B Buang, et al. · Zenodo (CERN European Organization for Nuclear Research)
Works count: 20
Citation count: 788
H-index: 12
I10-index: 12
Year
Topic
Type